{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:34:23Z","timestamp":1790292863015,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223897","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:33:43Z","timestamp":1571333623000},"page":"e0223897","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":115,"title":["Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1830-2213","authenticated-orcid":true,"given":"Laura E. M.","family":"Eurelings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle R.","family":"Miedema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil A. S. H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L. A.","family":"van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A. M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"issue":"4","key":"pone.0223897.ref001","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccm.2015.08.003","article-title":"The Diagnosis of Sarcoidosis","volume":"36","author":"P Govender","year":"2015","journal-title":"Clin Chest Med"},{"issue":"2","key":"pone.0223897.ref002","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"pone.0223897.ref003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0030-1262213","article-title":"Ocular sarcoidosis","volume":"31","author":"RP Baughman","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"pone.0223897.ref004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"JS Kim","year":"2009","journal-title":"American Heart Journal"},{"issue":"1","key":"pone.0223897.ref005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study","volume":"194","author":"P Ungprasert","year":"2016","journal-title":"Lung"},{"issue":"2","key":"pone.0223897.ref006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thx.39.2.143","article-title":"Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity","volume":"39","author":"GA Rossi","year":"1984","journal-title":"Thorax"},{"issue":"3","key":"pone.0223897.ref007","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"O Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"pone.0223897.ref008","doi-asserted-by":"crossref","first-page":"6103064","DOI":"10.1155\/2018\/6103064","article-title":"Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease","volume":"2018","author":"AF Karim","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"5","key":"pone.0223897.ref009","first-page":"597","article-title":"Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity","volume":"17","author":"LA Rubin","year":"1990","journal-title":"J Rheumatol"},{"issue":"1","key":"pone.0223897.ref010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.1990.tb05398.x","article-title":"Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus","volume":"82","author":"EJ ter Borg","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"pone.0223897.ref011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"AD Vorselaars","year":"2015","journal-title":"Respir Med"},{"issue":"3","key":"pone.0223897.ref012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","article-title":"On the role of sIL-2R measurements in rheumatoid arthritis and cancers","volume":"2005","author":"AM Witkowska","year":"2005","journal-title":"Mediators Inflamm"},{"issue":"5","key":"pone.0223897.ref013","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"LA Rubin","year":"1985","journal-title":"J Immunol"},{"issue":"3","key":"pone.0223897.ref014","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2567.2010.03308.x","article-title":"T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies","volume":"131","author":"CA Lindqvist","year":"2010","journal-title":"Immunology"},{"issue":"1\u20132","key":"pone.0223897.ref015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0047-6374(91)90071-7","article-title":"Soluble interleukin-2 receptor release defect in vitro in elderly subjects","volume":"59","author":"C Caruso","year":"1991","journal-title":"Mech Ageing Dev"},{"issue":"12","key":"pone.0223897.ref016","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1006\/cyto.1999.0509","article-title":"Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2","volume":"11","author":"H Kobayashi","year":"1999","journal-title":"Cytokine"},{"issue":"10","key":"pone.0223897.ref017","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","article-title":"Soluble IL-2Ralpha facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma","volume":"118","author":"ZZ Yang","year":"2011","journal-title":"Blood"},{"issue":"5","key":"pone.0223897.ref018","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","article-title":"Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers","volume":"156","author":"MW Ziegenhagen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0223897.ref019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","article-title":"Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis","volume":"21","author":"MW Ziegenhagen","year":"2003","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0223897.ref020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2015.01.015","article-title":"Conventional markers in determination of activity of sarcoidosis","volume":"25","author":"S Gungor","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"pone.0223897.ref021","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"S Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"issue":"5","key":"pone.0223897.ref022","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis","volume":"59","author":"T Kiko","year":"2018","journal-title":"Int Heart J"},{"issue":"3","key":"pone.0223897.ref023","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030084","article-title":"YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity","volume":"8","author":"P Uysal","year":"2018","journal-title":"Biomolecules"},{"issue":"1","key":"pone.0223897.ref024","doi-asserted-by":"crossref","first-page":"e0147258","DOI":"10.1371\/journal.pone.0147258","article-title":"Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis","volume":"11","author":"E Gundlach","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"pone.0223897.ref025","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","article-title":"Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis","volume":"135","author":"F Groen-Hakan","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"pone.0223897.ref026","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/1346-8138.13792","article-title":"Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement","volume":"44","author":"C Thi Hong Nguyen","year":"2017","journal-title":"J Dermatol"},{"key":"pone.0223897.ref027","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2016.04.011","article-title":"Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab","volume":"115","author":"HA Crommelin","year":"2016","journal-title":"Respir Med"},{"issue":"4","key":"pone.0223897.ref028","first-page":"735","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"U Costabel","year":"1999","journal-title":"Eur Respir J"},{"issue":"538","key":"pone.0223897.ref029","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/pgmj.46.538.530","article-title":"The late stages of pulmonary sarcoidosis","volume":"46","author":"JG Scadding","year":"1970","journal-title":"Postgrad Med J"},{"issue":"4","key":"pone.0223897.ref030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"E von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"pone.0223897.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"X Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"pone.0223897.ref032","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-015-8475-x","article-title":"Diagnosis of Sarcoidosis","volume":"49","author":"TE Wessendorf","year":"2015","journal-title":"Clinical Reviews in Allergy & Immunology"},{"issue":"3","key":"pone.0223897.ref033","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0009-9120(87)80123-6","article-title":"Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis","volume":"20","author":"PS Bunting","year":"1987","journal-title":"Clin Biochem"},{"issue":"119","key":"pone.0223897.ref034","first-page":"761","article-title":"Serum angiotensin converting enzyme activity in sarcoidosis as measured by a simple radiochemical assay","author":"DR Rohrbach MS","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"pone.0223897.ref035","unstructured":"Denyer M Fau\u2014Denyer M. Medical Statistics at a Glance."},{"issue":"8","key":"pone.0223897.ref036","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"T Fawcett","year":"2006","journal-title":"Pattern Recognition Letters"},{"key":"pone.0223897.ref037","doi-asserted-by":"crossref","unstructured":"Pepe MS. The statistical evaluation of medical tests for classification and prediction 2004. http:\/\/public.eblib.com\/choice\/publicfullrecord.aspx?p=1573145.","DOI":"10.1093\/oso\/9780198509844.001.0001"},{"key":"pone.0223897.ref038","volume-title":"Statistical methods in diagnostic medicine Hoboken","author":"Wiley I","year":"2011"},{"issue":"1","key":"pone.0223897.ref039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"WJ Youden","year":"1950","journal-title":"Cancer"},{"issue":"2","key":"pone.0223897.ref040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PRS.0b013e3181de24bc","article-title":"Identifying and Avoiding Bias in Research","volume":"126","author":"CJ Pannucci","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"pone.0223897.ref041","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its Associated Cutoff Point","volume":"47","author":"R Fluss","year":"2005","journal-title":"Biometrical Journal"},{"issue":"20","key":"pone.0223897.ref042","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"H Sato","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"pone.0223897.ref043","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/emj.20.1.54","article-title":"Observational research methods. Research design II: cohort, cross sectional, and case-control studies","volume":"20","author":"CJ Mann","year":"2003","journal-title":"Emerg Med J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:07:11Z","timestamp":1721884031000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223897"}},"subtitle":[],"editor":[{"given":"Masaki","family":"Mogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223897","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]}}}